In the present study, we therefore have assessed the molecular, cellular, morphological, and functional consequences of elevated muscle PGC-1α in a mouse model of dysferlinopathy. Here, PPARGC1A is linked to neuromuscular disease caused by qualitative or quantitative defects of dysferlin.